Ann M. Hanly's most recent trade in Vir Biotechnology Inc was a trade of 14,168 Common Stock done at an average price of $9.5 . Disclosure was reported to the exchange on Feb. 24, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Vir Biotechnology Inc | Ann M. Hanly | EVP & Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 9.45 per share. | 24 Feb 2025 | 14,168 | 117,901 (0%) | 0% | 9.5 | 133,936 | Common Stock |
| Vir Biotechnology Inc | Ann M. Hanly | EVP & Chief Technology Officer | 01 Apr 2024 | 2,711 | 132,069 (0%) | 0% | 10.1 | 27,251 | Common Stock | |
| Vir Biotechnology Inc | Ann Hanly M. | EVP & Chief Technology Officer | 22 Feb 2024 | 65,000 | 65,000 | - | - | Stock Option (Right to Buy) | ||
| Vir Biotechnology Inc | Ann Hanly M. | EVP & Chief Technology Officer | 22 Feb 2024 | 32,500 | 147,076 (0%) | 0% | 0 | Common Stock | ||
| Vir Biotechnology Inc | Hanly Ann M. | EVP & Chief Technology Officer | 22 Feb 2024 | 12,296 | 134,780 (0%) | 0% | 10.0 | 123,521 | Common Stock | |
| Vir Biotechnology Inc | Ann M. Hanly | Chief Technology Officer | 30 Mar 2023 | 2,627 | 114,576 (0%) | 0% | 22.8 | 59,817 | Common Stock | |
| Vir Biotechnology Inc | Ann M. Hanly | Chief Technology Officer | 22 Feb 2023 | 55,000 | 55,000 | - | - | Stock Option (Right to Buy) | ||
| Vir Biotechnology Inc | Ann M. Hanly | Chief Technology Officer | 22 Feb 2023 | 37,500 | 119,505 (0%) | 0% | 0 | Common Stock | ||
| Vir Biotechnology Inc | Ann M. Hanly | Chief Technology Officer | 22 Feb 2023 | 2,302 | 117,203 (0%) | 0% | 26.0 | 59,790 | Common Stock | |
| Vir Biotechnology Inc | Ann M. Hanly | Chief Technology Officer | 30 Mar 2022 | 2,627 | 81,473 (0%) | 0% | 26.2 | 68,925 | Common Stock | |
| Vir Biotechnology Inc | Ann M. Hanly | Chief Technology Officer | 22 Feb 2022 | 53,500 | 84,100 (0%) | 0% | 0 | Common Stock | ||
| Vir Biotechnology Inc | Ann M. Hanly | Chief Technology Officer | 22 Feb 2022 | 47,000 | 47,000 | - | - | Stock Option (Right to Buy) | ||
| Vir Biotechnology Inc | Ann M. Hanly | Chief Technology Officer | 29 Nov 2021 | 11 | 11 (0%) | 0% | 45.5 | 500 | Common Stock | |
| Vir Biotechnology Inc | Ann M. Hanly | Chief Technology Officer | 29 Mar 2021 | 60,000 | 60,000 | - | - | Employee Stock Option (Right to Buy) | ||
| Vir Biotechnology Inc | Ann M. Hanly | Chief Technology Officer | 29 Mar 2021 | 30,000 | 30,000 (0%) | 0% | 0 | Common Stock |